Established in 1982, this Manufacturer is a CTD dossier owner and manufacturer with a global presence spanning over 10 countries and regions, including Southeast Asia and North America. With nearly 1,000 employees, it operates GMP-certified facilities in Taiwan, producing tablets, capsules, and injectable formulations. As a GMP manufacturer, it holds certifications such as PIC/S GMP, EU GMP, and FDA 21 CFR compliance. The Manufacturer's subsidiaries specialize in innovative drug development, focusing on central nervous system and oncology therapeutics. Recognized as a CTD dossier owner and manufacturer, it continues to expand its reach as a GMP manufacturer and CTD dossier owner and manufacturer.